Biotech Piramal Pharma Solutions Highlights Strong Performance Across More Than 200 Customer Audits June 22, 2026
Biotech CureGene Achieves First Participant Dosed in U.S. Pivotal Trial for Evategrel (CG-0255), a Best-in-Class Antiplatelet Drug, Accelerating Global Commercialization June 21, 2026
Biotech SOPHiA GENETICS Announces Closing of $57.5 Million Public Offering of Ordinary Shares With Full Exercise of the Underwriters’ Option to Purchase Additional Shares June 20, 2026
Biotech Deck Bio to Present Multi-pMHC T Cell Engager Platform at the 8th T-Cell Engager Therapeutics Summit and BIO 2026 June 19, 2026
Biotech ZYUS Life Sciences Corporation Announces Closing of Third Tranche of Secured Loan Financing June 18, 2026
Biotech SOPHiA GENETICS Announces Pricing of $50 Million Public Offering of Ordinary Shares June 17, 2026
Biotech PLEOPHARMA TO PRESENT NEWDATA ON CANNABIS WITHDRAWAL In PATIENTS WITH CANNABIS USE DISORDER AND PHASE 2 PP-01 RESULTS AT THE COLLEGE ON PROBLEMS OF DRUG DEPENDENCE 88TH ANNUAL SCIENTIFIC MEETING June 16, 2026
Biotech Lundbeck presents new Phase II asedebart data in Cushing’s disease at ENDO 2026 June 15, 2026
Biotech Lilly to present initial clinical data for first-in-class type II JAK2 inhibitor in patients with previously treated myelofibrosis at the 2026 EHA Annual Meeting June 14, 2026